Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SUNY researchers discover inhibitors of PDC activity, describe use as anticancer agents

June 16, 2000

Xeloda approved in New Zealand as treatment for colorectal cancer

June 16, 2000

IDM signs cancer vaccine agreement with Sanofi-Synthelabo

June 16, 2000

Synthesis, activity and use of new inhibitors of protein farnesyltransferase

June 15, 2000

Fungally produced compound active against human tumor cell lines

June 15, 2000

Ligand receives approvable letter from FDA for Targretin Gel

June 15, 2000

Agouron and PPD Discovery create anticancer genomics alliance

June 15, 2000

AVI BioPharma demonstrates promise of new telomerase inhibitor

June 15, 2000

Trial of therapeutic agent for myelodysplastic syndrome indicates even greater potential

June 14, 2000

Preparation and use of new thiazole antitumor agents acting on cdk/cyclin complexes

June 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...